Article
A Multi-Level Analysis of Barriers and Promoting Factors to Cascade Screening Uptake Among Male Relatives of BRCA1/2 Carriers: A Qualitative Study.
Psycho-oncology - 1 May 2025
Ongaro G, Hamilton J G, Groner V, Hay J L, Calvello M, Oliveri S, Bonanni B, Feroce I, Pravettoni G
Abstract excerpt
BACKGROUND: Pathogenic variants in the BRCA1/2 genes significantly elevate risks of breast, ovarian, prostate, and pancreatic cancer. Clinical guidelines recommend cascade screening (CS) to identify at-risk family members and advance genetically targeted disease prevention. However, despite the benefits of CS, testing uptake remains suboptimal, particularly among male first-degree relatives (FDRs) of female...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
